He aha te tikanga o te "Maama"?
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Kuri Achromatopsia Momo 2 I te Hepara Tiamana (ACHM2-GS)
Achromatopsia Type 2 is a genetic condition that affects German Shepherds, leading to color vision deficiencies and potential vision impairment. DNA testing for this condition is crucial for responsible breeding practices, ensuring that potential puppies are screened for this hereditary issue. By identifying carriers of the gene, breeders can make informed decisions to reduce the prevalence of Achromatopsia Type 2 in the breed. Early detection through DNA tests not only aids in better health management but also contributes to the overall well-being of German Shepherds. If you're a breeder or dog owner, consider investing in a DNA test for Achromatopsia Type 2 to promote healthier litters. Protect your beloved German Shepherd by understanding their genetic health risks today!
Whakapoto: ACHM2-GS
Irakētanga kua tātarihia: CNGA3 c.1270C>T
Tukunga iho: Autosomal Recessive
Acronym
ACHM2-GS
Te auau kua tirohia
Te taumahatanga haumanu
Te whakarōpūtanga haumanu
Nga mate ophthalmic
Te whakarerekētanga kua tātarihia
CNGA3 c.1270C>T
p.(R424W)
p.(R424W)
Te tikanga tuku iho
Autosomal Recessive (Kua oti)
Whakarāpopototanga whakamātautau:
Achromatopsia Type 2 is a genetic condition in German Shepherds that affects their ability to perceive colors, rendering them essentially colorblind. This condition is caused by mutations in the CNGB3 gene, which plays a critical role in the functioning of retinal cells. A DNA test can identify carriers of this mutation, helping breeders make informed decisions to reduce the prevalence of the disorder. Affected dogs may also experience sensitivity to bright light and reduced visual acuity. Early detection through genetic testing can aid in managing the condition and improving the quality of life for these dogs.
Kei te waatea mai i te kete: Basic
Kua whakauruhia tenei whakamatautau DNA mai i ta maatau kete Basic — he waahanga ano hoki o nga kete Basic, Standard, Advanced, Complete.
Tirohia nga Puka Whakamatau DNA →Kōwhirihia te mōkihi e pai ana ki to momo whakatipu, rautaki hauora ranei o au kararehe.
Understanding Achromatopsia Type 2 in German Shepherds
Achromatopsia Type 2 is a genetic condition that affects the vision of German Shepherds, leading to a form of color blindness. This disorder is characterized by a deficiency in cone photoreceptors, resulting in an inability to perceive colors. Affected dogs typically experience a limited visual spectrum, primarily being able to see in shades of gray.
Nga Tohu Hauora me nga Tohu
Dogs with Achromatopsia Type 2 may exhibit a range of symptoms that can impact their quality of life. Common signs include difficulty seeing in bright light, which may cause them to squint or avoid sunlight. These dogs may also show signs of anxiety or confusion in unfamiliar environments due to their compromised vision. Additionally, they may have a reduced ability to track moving objects, which can affect their overall agility and playfulness.
Genetics and Inheritance
The condition is inherited in an autosomal recessive manner, meaning that both parents must carry the gene mutation for an offspring to be affected. The gene responsible for Achromatopsia Type 2 has been identified, allowing for targeted DNA testing. Identifying carriers and affected individuals through genetic testing can help breeders make informed decisions to reduce the prevalence of this condition in the breed.
Diagnosis and Management
Diagnosis of Achromatopsia Type 2 typically involves a combination of clinical examination and DNA testing. While there is currently no cure for this condition, management strategies can be implemented to enhance the quality of life for affected dogs. Providing a safe and stable environment, minimizing exposure to bright lights, and ensuring regular check-ups can help in managing the symptoms.
Whakamutunga
Achromatopsia Type 2 is a significant condition that can affect German Shepherds, impacting their vision and overall well-being. Understanding the genetics behind this disorder is crucial for breeders and pet owners alike, as it allows for informed decisions that can ultimately lead to healthier dogs. With proper diagnosis and management, affected dogs can lead fulfilling lives despite their visual limitations.
He momo kua tohua mo te whakamatautau: Achromatopsia Momo 2 I te Hepara Tiamana (ACHM2-GS)
- American White Shepherd Dog
- German Shepherd Dog
- Shiloh Shepherd
- Swiss White Shepherd Dog
🧬 Interpretation of genotypes ACHM2-GS
momoira
Tūnga
🟡 N/N
Kaikawe kore - Karekau he Morearea
🟡 N/ACHM2-GS
Kaikawe - Karekau he morearea
❌ ACHM2-GS/ACHM2-GS
Kua Paa - I Te Morearea
FAQ: te mohio ki te whakamaoritanga
He taumaha te "Kaikawe"?
Kao. He hauora te kararehe engari ka taea e ia te tuku i te huringa ki tona uri.
He aha mena ka "Paea" tetahi kararehe?
E rua nga kape whakarereke. Ko nga tohu haumanu kei te tumanakohia te mate. Kaua e whakatipuria.
He aha nga rereketanga i waenga i te tane / wahine?
Ko etahi o nga mate he hononga-a-ira, no reira ka rereke o raatau korero i runga i te ira kararehe.
Matapaea te uri
N/N (kaikawe-kore)
N/ACHM2-GS (Kaikawe)
ACHM2-GS/ACHM2-GS (Ka pangia)
FAQ Whakamātautau DNA
He aha ta tenei whakamatautau DNA ka kitea?
This DNA test detects the mutation associated with Achromatopsia Type 2 In German Shepherd (ACHM2) in order to identify clear, carrier, or at-risk animals.
He aha te whakamatautau i te kararehe whakatipu?
Ko te whakamatautau DNA ka awhina i nga kaiwhakawhanake ki te whakamahere i nga hononga haumaru ake me te whakaiti i te tupono ki te tuku i te huringa ki nga uri.
He aha te tikanga tuku iho o tenei whakamatautau?
Ko te tikanga tuku iho mo tenei whakamatautau ko Autosomal Recessive.
Ko tehea whakarerekētanga ka tātarihia i roto i tenei whakamatautau?
This test analyses the mutation CNGA3 c.1270C>T.
Ko te kararehe kawe kawe ka mate?
Ehara i te mea. Ko te whakamaoritanga ka whakawhirinaki ki te tauira tuku iho me te momo momo ira ka puta.
Tohutoro
Tanaka Naoto, Dutrow Emily V, Miyadera Keiko, Delemotte Lucie, MacDermaid Christopher M, Reinstein Shelby L, Crumley William R, Dixon Christopher J, Casal Margret L, Klein Michael L, Aguirre Gustavo D, Tanaka Jacqueline C, Guziewicz Karina E. Canine CNGA3 Gene Mutations Provide Novel Insights into Human Achromatopsia-Associated Channelopathies and Treatment. PLoS One. 2015 Sep 25;10(9):e0138943. doi: 10.1371/journal.pone.0138943. eCollection 2015.